SALT LAKE CITY, Oct. 7, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that, through ...
Cancer cases are rising among people under 50 for several cancer types, with a new international analysis finding significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results